Cormedix's market cap is currently $902.36M. The company's EPS TTM is $0.29; its P/E ratio is 15.48; Cormedix is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $0.43. See an overview of income statement, balance sheet, and cash flow financials.
